美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Nasdaq Biotechnology ETF

34.69

-0.4365-1.24%

盤後：34.710.0207+0.06%19:30 EDT

成交量：2.55萬

成交額：88.53萬

市值：9,643.63萬

市盈率：- -

高：35.13

開：35.13

低：34.63

收：35.13

52周最高：36.84

52周最低：23.42

股本：278.00萬

流通股本：278.00萬

量比：1.14

換手率：0.92%

股息：0.26

股息率：0.74%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發

石藥集團(01093)：SYH2069注射液用於治療成人2型糖尿病的II期臨床試驗在中國首個研究中心正式啓動

智通财经网

苑東生物：EP-0226片完成I期臨床試驗推進II期籌備

陽光諾和(688621.SH)：在研項目BTP0427的臨床試驗申請獲得批准

陽光諾和：BTP0427規格I、II獲臨床試驗批准

ST百靈(002424.SZ)子公司糖寧通絡乳膏獲批臨床試驗

ST百靈：全資子公司獲2026年藥物臨床試驗批准通知書

港股異動 | 恒瑞醫藥(01276)尾盤漲近4% 同日獲兩份臨床試驗批准覆蓋銀屑病和卒中預防

創新藥概念股表現活躍

香港施政報告：邀請廣深企業參與大學城建設河套大灣區國際臨床試驗所投入運作

江小涓：這個數據大家不要吃驚，未來幾年還要漲

凤凰网港股

創新藥概念局部走強恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來

百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟

恒瑞醫藥(01276.HK)：注射用瑞卡西單抗獲得藥物臨床試驗批准通知書

中國生物製藥：本集團附屬公司正大天晴藥業集團股份有限公司自主研發的國家 1 類創新藥 TQB2102 注射液「HER2

百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進

Contineum 股價下跌 9.9%，原因是其與強生合作研發的抗抑鬱藥中期臨床試驗失敗。

吉利德科學攜手巴西衞生部，共促Lenacapavir本地化生產新篇章

吉利德科學：持續探索與泛美衞生組織合作，助力各國準備好並擴大長效艾滋病預防措施的普及

吉利德科學公司高管在電話會議上表示，HIV藥物市場的增長預計將在未來幾個季度內迴歸至2%至3%的正常水平。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IBBQ/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.6893,"timestamp":1789761600000,"preClose":35.1258,"halted":0,"volume":25488,"hourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"delay":0,"changeRate":-0.012426763233862154,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"休市中","change":-0.4365,"latestTime":"09-18 16:00:00 EDT","open":35.13,"high":35.13,"low":34.6296,"amount":885294.380736,"amplitude":0.014246,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":35.11978,"aum":97633023.51978,"dividendRate":0.007406,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"volumeRatio":1.1394951737825971,"impliedVol":0.0457,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1394951737825971,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.014246,"preClose":35.1258,"low":34.6296,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.6893,"eps":0,"divideRate":0.007406,"volume":25488,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667074086","title":"Sling Therapeutics 籌集 1.23 億美元，用於推進甲狀腺相關眼病藥物的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667074086","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667074086?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:01","pubTimestamp":1789556485,"startTime":"0","endTime":"0","summary":"Sling Therapeutics 筹集 1.23 亿美元，用于推进甲状腺相关眼病药物的研发Kunal Das/Siddhi Mahatole路透9月16日-药物研发公司Sling Therapeutics周三表示，已筹集1.23亿美元，用于推进其用于治疗甲状腺眼病的实验性口服药物的后期临床试验。该疾病会导致眼周发炎和肿胀，进而可能引发眼球突出和视力丧失。作为此次融资协议的一部分，Sling还任命了Forbion的Regina Salvat和Sectoral Asset Management的Franois Beaubien加入其董事会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4T4580NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","TBXU","IBBQ","PBE","LU1023059063.AUD","BK4534","LU2242646821.SGD","LU0109394709.USD","LU2242652126.USD","AMGN","IBB","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4533","LU2089984988.USD","BIB","BK4588","BK4585","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","SG9999001440.SGD","PJP","LU0289739699.SGD","BBH","BK4581","VRDN","LU0058720904.USD","BK4139","LU1057294990.SGD","LU2112291526.USD","LU1983299246.USD","BK4566","IE0002141913.USD","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU0122379950.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4599","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667020436","title":"石藥集團(01093)：SYH2069注射液用於治療成人2型糖尿病的II期臨床試驗在中國首個研究中心正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2667020436","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667020436?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 18:39","pubTimestamp":1789555160,"startTime":"0","endTime":"0","summary":"石药集团(01093)发布公告，集团开发的SYH2069注射液(“该产品”)用于治疗成人2型糖尿病的II期临床试验(SYH2069-003)已在中国首个研究中心正式启动。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0072913022.USD","HK0000165453.HKD","KURE","LU0140636845.USD","LU1951186391.HKD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","BMED","LU1008478684.HKD","LU1226288170.HKD","IE00B5MMRT66.SGD","IBBQ","LU0315179316.USD","LU0326950275.SGD","BK1521","LU1328277881.USD","LU1152091754.HKD","IE0008368742.USD","BK1191","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1813983027.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1515","LU1152091168.USD","SG9999004220.SGD","IBBJ","01093","IE00B543WZ88.USD","LU0501845795.SGD","LU1226287875.USD","PSYK","LU1226288253.USD","MDTX","LU1226287529.USD","LU0314109678.HKD","LU1226287792.SGD","LU0880133367.SGD","IE0008369823.USD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601469","title":"苑東生物：EP-0226片完成I期臨床試驗 推進II期籌備","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667601469?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:36","pubTimestamp":1789551391,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","IBBJ","PSYK","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601451","title":"陽光諾和(688621.SH)：在研項目BTP0427的臨床試驗申請獲得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601451","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667601451?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:34","pubTimestamp":1789551264,"startTime":"0","endTime":"0","summary":"智通财经APP讯，阳光诺和(688621.SH)发布公告，近日，公司及全资子公司江苏诺和必拓新药研发有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，公司在研项目BTP0427的临床试验申请获得批准。BTP0427拟用于治疗射血分数降低的慢性心力衰竭，适用于心脏收缩功能障碍的慢性心力衰竭患者的对症治疗，作为替代疗法，用于已经接受相同剂量的β受体阻滞剂和窦房结If电流抑制剂联合治疗且病情得到控制的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","PSYK","IBBQ","688621","IBBJ","BK0216","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667019476","title":"陽光諾和：BTP0427規格I、II獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2667019476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667019476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:30","pubTimestamp":1789551020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","IBBJ","BMED","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667609196","title":"ST百靈(002424.SZ)子公司糖寧通絡乳膏獲批臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2667609196","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667609196?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:02","pubTimestamp":1789549346,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST百灵(002424.SZ)发布公告，近日，公司全资子公司百灵毓秀(珠海)医药有限公司(简称“百灵毓秀”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，公司糖宁通络乳膏临床试验申请符合药品注册的有关要求，在进一步完善临床试验方案的基础上，同意开展用于糖尿病足溃疡的临床试验。本次公司全资子公司百灵毓秀收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意糖宁通络乳膏开展用于糖尿病足溃疡的临床试验，系公司糖宁通络管线重要阶段性研发成果，有利于推进公司糖尿病并发症“内服+外用”治疗体系布局，糖宁通络乳膏获得临床试验批准暂不会对公司当期业绩产生重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0239","IBBQ","002424","MDTX","BK0183","PSYK","IBBJ","BMED","BK0028","BK0077","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667099276","title":"ST百靈：全資子公司獲2026年藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667099276","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667099276?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 16:59","pubTimestamp":1789549183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","IBBJ","PSYK","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605559","title":"港股異動 | 恒瑞醫藥(01276)尾盤漲近4% 同日獲兩份臨床試驗批准 覆蓋銀屑病和卒中預防","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605559","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:49","pubTimestamp":1789544947,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，恒瑞医药尾盘涨近4%。截至发稿，涨3.88%，报45.5港元，成交额1.53亿港元。消息面上，9月15日，恒瑞医药公告称，子公司福建盛迪医药的HRS-4139片获国家药监局临床试验批准，同意开展中重度斑块状银屑病的临床试验。同日，子公司广东恒瑞医药的注射用瑞卡西单抗获临床试验批准，同意开展Ⅲ期临床试验，适应证为用于颅内动脉粥样硬化性狭窄的成人患者以降低卒中复发风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2097828714.EUR","LU2543165471.USD","PSYK","IBBJ","600276","LU1997244956.HKD","LU2097828474.EUR","LU1969619763.USD","BK4585","LU2148510915.USD","KCAI","BK0188","BMED","LU2328871848.SGD","LU0359202008.SGD","LU1064131003.USD","LU1146622755.USD","LU2097828805.USD","BK4588","BK0183","LU1655091616.SGD","LU0405327148.USD","LU1023057109.AUD","BK0028","01276","LU1328615791.USD","LU2495084118.USD","LU1255011170.USD","LU2580892862.HKD","LU2488822045.USD","LU1997245177.USD","LU1781817850.SGD","LU2580892789.USD","LU1997245094.SGD","BK0012","MDTX","BK0196","BK0060","IBBQ","LU0359201612.USD","LU1580142542.USD","VXUS","LU2289578879.USD","BK0239","LU0405327494.USD","LU0359201885.HKD","LU2097828631.EUR","LU1820825898.SGD","LU2097828557.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667724676","title":"創新藥概念股表現活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667724676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667724676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 13:18","pubTimestamp":1789535894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667672921","title":"香港施政報告：邀請廣深企業參與大學城建設 河套大灣區國際臨床試驗所投入運作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667672921","media":"港股一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667672921?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 13:07","pubTimestamp":1789535220,"startTime":"0","endTime":"0","summary":"李家超指，将邀请广深创新及科技园有限公司及新田科技城有限公司加入开发行列，参与大学城建设，以加快项目建造发展。李家超同时表示，河套香港园区的粤港澳大湾区国际临床试验所已投入运作，由香港特区政府全资拥有并委托香港大学营运，与深圳园区协同推动医疗创新。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkyx/2026-09-16/doc-iniryzmc4906916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BMED","IBBQ","MDTX","PSYK","159983","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667674545","title":"江小涓：這個數據大家不要吃驚，未來幾年還要漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667674545","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667674545?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:44","pubTimestamp":1789530285,"startTime":"0","endTime":"0","summary":"江小涓表示，我国创新药产业正迎来全球化爆发新阶段，产业规模与国际影响力持续攀升。江小涓解释，依托AI平台找到治病靶点、匹配新化合物，我国拥有了新药青苗，成果本身很好，但还只是一棵青苗，还需要把好苗对外授权进行进一步培育和商业化。江小涓进一步解释，AI会使产业链出现一些变化。江小涓说，“所以AI for Science不仅仅是我们把自己做好，还会引起全球产业链非常快速的调整，这些行业都是如此，这是一个非常大的变化。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8wSeX6t1BpL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","LNGR","VTHR","ARTY","BK1574","MEDX","CHAT","06978","AGIX","IBBQ","AIPO","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上，国金证券表示，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。诚通证券表示，2025年为创新药海外授权BD大年，2026H1我国创新药海外授权BD交易继续大幅增长，总交易金额已接近1000亿美元，国产创新药已从偶发性出海转变为系统性趋势。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","LU1997244956.HKD","LU1023057109.AUD","LU0307460666.USD","LU0405327148.USD","LU2097828557.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","LU0140636845.USD","LU0588546209.SGD","159992","LNGR","09688","BK1515","LU0128526141.USD","MEDX","LU0043850808.USD","LU0359201612.USD","LU0516422952.EUR","LU2097828805.USD","BK1574","06978","LU1655091616.SGD","IE00B0JY6N72.USD","LU0561508036.HKD","BK0183","600276","LU0456846285.SGD","LU0516423174.USD","LU2580892789.USD","LU2488822045.USD","LU1580142542.USD","BK0239","02637","LU0327786744.USD","01177","BK0060","IBBQ","LU0348827113.USD","LU1255011170.USD","01477","LU1820825898.SGD","LU2148510915.USD","LU1328615791.USD","02269","LU1146622755.USD","LU0348825331.USD","BK0188","LU0417516902.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667267605","title":"百時美施貴寶就安進擬推出的Opdivo生物類似藥提起訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667267605?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2468319806.SGD","LU1868836757.USD","BBH","LU1670711123.USD","XPH","PBE","LU1983299246.USD","LU0225284248.USD","TBXU","LU1868837300.USD","LU2322448957.HKD","LU0320765992.SGD","LU2272731600.USD","LU1992135399.USD","LU1023059063.AUD","LU1261432733.SGD","BMY","LU2473716301.USD","IBBQ","IBB","BK4139","AMGN","LU0289739699.SGD","LU1236620834.HKD","FTXH","BK4534","LU2272731865.HKD","LU1868836591.USD","LU0868494617.USD","LU1883839398.USD","PJP","LU1989771016.USD","BK4585","LU0109394709.USD","IE0009355771.USD","BK4566","LU1236620750.USD","LU0114720955.EUR","BK4533","IE00B4R5TH58.HKD","LU0225771236.USD","LU0061475181.USD","BK4559","BIB","LU2125154778.USD","LU0058720904.USD","PPH","BK4588","IE00BSNM7G36.USD","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667204626","title":"恒瑞醫藥(01276.HK)：注射用瑞卡西單抗獲得藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2667204626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667204626?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 07:38","pubTimestamp":1789515492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","IBBJ","BMED","PSYK","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667530620","title":"中國生物製藥：本集團附屬公司正大天晴藥業集團股份有限公司自主研發的國家 1 類創新藥 TQB2102 注射液「HER2","url":"https://stock-news.laohu8.com/highlight/detail?id=2667530620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667530620?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 07:10","pubTimestamp":1789513851,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629132","title":"百時美施貴寶就奧普迪沃擬推出的生物類似藥起訴安進","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629132","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629132?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:29","pubTimestamp":1789493363,"startTime":"0","endTime":"0","summary":"百时美施贵宝就奥普迪沃拟推出的生物类似药起诉安进Blake Brittain路透9月15日-百时美施贵宝公司和小野制药公司已在特拉华州联邦法院起诉安进公司，试图阻止安进公司在美国推出其畅销癌症免疫疗法药物“欧迪沃”的生物类似药。百时美施贵宝和小野制药的发言人尚未立即回应置评请求。共同开发“欧狄沃”的百时美施贵宝和小野制药指控，安进的生物类似药将侵犯该药物所涉及的七项美国专利，并请求法院在专利有效期内禁止该生物类似药的销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4T4571DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU1074936037.SGD","LU0868494617.USD","LU0321505439.SGD","LU0306807586.USD","IHE","LU1093756168.USD","LU2089984988.USD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0321505868.SGD","LU2125154935.USD","BK4533","LU2242646821.SGD","TBXU","BBH","IE00B2B36J28.USD","LU1868836914.USD","LU1585245621.USD","BK4534","BIB","LU0225284248.USD","LU0267386448.USD","LU0306806265.USD","LU2468319806.SGD","LU1670710661.SGD","LU0114720955.EUR","LU2112291526.USD","BK4139","LU1057294990.SGD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0456855351.SGD","LU1323610961.USD","LU2360032135.SGD","BMY","IE00BSNM7G36.USD","LU0061475181.USD","BK4599","FTXH","LU1430594728.SGD","IBBQ","LU1571399168.USD","LU1236620750.USD","BK4581","IE0009355771.USD","LU1061106388.HKD","BK4566","LU0109394709.USD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU1261432733.SGD","LU0096364046.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU1670711123.USD","LU1236620834.HKD","BK4007","LU1093756325.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","PJP","04332","LU0985481810.HKD","LU1989771016.USD","LU1983299246.USD","LU2133065610.SGD","LU0237698245.USD","LU2125154778.USD","LU0058720904.USD","LU2242652126.USD","LU1868836591.USD","LU0225771236.USD","LU0320765992.SGD","LU1868837136.USD","SG9999001440.SGD","BK4559","LU1670711040.USD","LU1868836757.USD","LU1868837300.USD","PBE","AMGN","BK4588","BK4532","LU1883839398.USD","IE00BFXG1179.USD","LU1023059063.AUD","IBB","LU2596442595.SGD","LU1670710588.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667296846","title":"Contineum 股價下跌 9.9%，原因是其與強生合作研發的抗抑鬱藥中期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667296846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667296846?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:17","pubTimestamp":1789492646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B42XCP33.USD","IBBQ","LU1162221912.USD","FHLC","LU1585245621.USD","XLV","LU1929549753.HKD","MEDX","LU2417539215.USD","LU0689626769.HKD","LU0545562505.USD","LU1228905540.USD","LU1244550577.SGD","LU1629891620.HKD","LU1674673691.USD","LU2403377893.USD","IHE","LU0820561818.USD","LU0889566641.SGD","LU1430594728.SGD","LU1032955483.USD","GDOC","LU0072461881.USD","IE00BFXG1179.USD","IBBJ","IXJ","JDOC","LU0345769631.USD","LU0289739699.SGD","BK4568","BMED","PJP","PSYK","LU2468319806.SGD","JNJ","VHT","FTXH","IE00BJT1NW94.SGD","RXL","IE000SO60NU8.SGD","LU0432979614.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","IYH","IE00B19Z3B42.SGD","LU1989771016.USD","LU0792757196.USD","MDTX","TRUH","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科學攜手巴西衞生部，共促Lenacapavir本地化生產新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露，正积极与巴西卫生部探索合作良机，旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措，无疑为巴西医药产业自主化进程注入了强劲动力。据悉，双方的洽谈聚焦于如何深化协作，以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir，作为一款备受瞩目的长效抗逆转录病毒药物，其本地化生产若能落地，对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1430594728.SGD","TMED","SG9999015978.USD","LU0234570918.USD","LU2357627491.SGD","IE00BKVL7J92.USD","BIB","LU2089984988.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4585","IBBQ","BK4588","LU0320765992.SGD","LU1934455194.USD","LU1839511570.USD","LU0965509283.SGD","LU1066053197.SGD","LU1571399168.USD","BK4566","LU2112291526.USD","LU0965508806.USD","BK4550","SG9999015986.USD","SG9999015945.SGD","LU0889565916.HKD","LU0861579265.USD","BK4583","LU1674673428.USD","LU2324357040.USD","LU2468319806.SGD","BK4578","LU1934455277.USD","IE00B19Z3581.USD","LU0058720904.USD","IBB","LU0823416689.USD","LU0965509010.AUD","LU1023059063.AUD","LU1037948897.HKD","LU1057294990.SGD","LU0882574055.USD","IE00B7SZLL34.SGD","BBH","IE00B3T34201.USD","GILD","BMED","BK4568","IE0002270589.USD","LU1585245621.USD","BK4139","LU0114720955.EUR","TBXU","LU1934455863.HKD","LU0965509101.SGD","LU0859254822.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1778281490.HKD","LU1037948541.HKD","LU2087621335.USD","SG9999015952.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU1061106388.HKD","MEDI","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科學：持續探索與泛美衞生組織合作，助力各國準備好並擴大長效艾滋病預防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）宣布，将继续探索与泛美卫生组织（PAHO）的合作机会，以支持各国做好充分准备，并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系，尤其是针对中低收入国家的需求，通过技术转移、能力建设及供应链优化等途径，加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战，确保相关资源能够高效、公平地分配至最需要的人群，从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2087621335.USD","BK4568","BBH","LU0058720904.USD","BIB","LU1674673428.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU2089984988.USD","TBXU","IE00B19Z3581.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU1061106388.HKD","IE00BSNM7G36.USD","LU1934455277.USD","LU2324357040.USD","SG9999015986.USD","LU1778281490.HKD","LU0965509010.AUD","IBBQ","LU1585245621.USD","IBB","LU0889565916.HKD","LU0122379950.USD","LU0965509283.SGD","BK4578","LU0965508806.USD","LU0861579265.USD","LU1023059063.AUD","LU0320765992.SGD","LU1674673691.USD","LU0109394709.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1934455194.USD","LU2468319806.SGD","MEDI","SG9999015978.USD","BK4583","SG9999015952.SGD","BK4139","BK4585","LU0114720955.EUR","LU1057294990.SGD","LU0882574055.USD","IE00B3T34201.USD","LU1066051498.USD","LU0823416689.USD","BK4550","LU0859254822.USD","LU1037948541.HKD","LU2357627491.SGD","BMED","GILD","LU0965509101.SGD","TMED","SG9999015945.SGD","LU1430594728.SGD","LU1066053197.SGD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4566","BK4532","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667623020","title":"吉利德科學公司高管在電話會議上表示，HIV藥物市場的增長預計將在未來幾個季度內迴歸至2%至3%的正常水平。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667623020","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667623020?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 23:11","pubTimestamp":1789485099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0122379950.USD","LU1066053197.SGD","MEDI","LU0965509101.SGD","LU2112291526.USD","BK4566","IE00B19Z3581.USD","LU1066051498.USD","LU0882574055.USD","IE00B19Z3B42.SGD","IBBQ","IE00BKVL7J92.USD","LU0114720955.EUR","LU1674673691.USD","LU1430594728.SGD","BIB","LU0889565916.HKD","LU0965509283.SGD","LU1934455277.USD","IE0002270589.USD","BK4550","BBH","LU0058720904.USD","LU1037948541.HKD","LU1057294990.SGD","BK4588","LU1674673428.USD","LU1839511570.USD","SG9999015952.SGD","LU1585245621.USD","BK4532","LU1061106388.HKD","BMED","LU0289739699.SGD","TMED","BK4139","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1934455863.HKD","GILD","SG9999015978.USD","IBB","TBXU","LU0859254822.USD","LU0234570918.USD","LU0320765992.SGD","LU0965509010.AUD","SG9999015945.SGD","LU2324357040.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":3,"totalSize":213,"code":"91000000","status":"200"}]}}